Promoter Regions, Genetic
"Promoter Regions, Genetic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.
| Descriptor ID |
D011401
|
| MeSH Number(s) |
G02.111.570.080.689.675 G05.360.080.689.675 G05.360.340.024.340.137.750.680
|
| Concept/Terms |
Promoter Regions, Genetic- Promoter Regions, Genetic
- Genetic Promoter Region
- Genetic Promoter Regions
- Promoter Region, Genetic
- Region, Genetic Promoter
- Regions, Genetic Promoter
- Promoter Regions
- Promoter Region
- Region, Promoter
- Regions, Promoter
- Promotor Regions
- Promotor Region
- Region, Promotor
- Regions, Promotor
rRNA Promoter- rRNA Promoter
- Promoter, rRNA
- Promoters, rRNA
- rRNA Promoters
Promoter, Genetic- Promoter, Genetic
- Genetic Promoter
- Genetic Promoters
- Promoters, Genetic
- Promotor, Genetic
- Genetic Promotor
- Genetic Promotors
- Promotors, Genetic
Pseudopromoter, Genetic- Pseudopromoter, Genetic
- Genetic Pseudopromoter
- Genetic Pseudopromoters
- Pseudopromoters, Genetic
|
Below are MeSH descriptors whose meaning is more general than "Promoter Regions, Genetic".
Below are MeSH descriptors whose meaning is more specific than "Promoter Regions, Genetic".
This graph shows the total number of publications written about "Promoter Regions, Genetic" by people in this website by year, and whether "Promoter Regions, Genetic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 1 | 3 |
| 2004 | 2 | 4 | 6 |
| 2005 | 1 | 1 | 2 |
| 2006 | 3 | 2 | 5 |
| 2007 | 2 | 3 | 5 |
| 2008 | 1 | 2 | 3 |
| 2009 | 0 | 5 | 5 |
| 2010 | 3 | 3 | 6 |
| 2011 | 2 | 5 | 7 |
| 2012 | 0 | 3 | 3 |
| 2013 | 1 | 6 | 7 |
| 2014 | 1 | 6 | 7 |
| 2015 | 1 | 3 | 4 |
| 2016 | 1 | 8 | 9 |
| 2017 | 37 | 108 | 145 |
| 2018 | 17 | 73 | 90 |
| 2019 | 5 | 22 | 27 |
| 2020 | 1 | 8 | 9 |
| 2021 | 1 | 6 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Promoter Regions, Genetic" by people in Profiles.
-
Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice. JCI Insight. 2021 10 08; 6(19).
-
Luciferase reporter assays to monitor interferon signaling modulation by SARS-CoV-2 proteins. STAR Protoc. 2021 12 17; 2(4):100781.
-
SARS-CoV-2 NSP12 Protein Is Not an Interferon-ß Antagonist. J Virol. 2021 08 10; 95(17):e0074721.
-
SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity. Viruses. 2021 07 23; 13(8).
-
Epigenetic and transcriptional control of interferon-ß. J Exp Med. 2021 09 06; 218(9).
-
Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1. Front Immunol. 2021; 12:648815.
-
Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues. Curr Cancer Drug Targets. 2021 07 05; 21(5):428-442.
-
Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles. Int J Mol Sci. 2021 Jun 28; 22(13).
-
Interplay between SARS-CoV-2-derived miRNAs, immune system, vitamin D pathway and respiratory system. J Cell Mol Med. 2021 08; 25(16):7825-7839.
-
Stress Decreases Host Viral Resistance and Increases Covid Susceptibility in Embryonic Stem Cells. Stem Cell Rev Rep. 2021 12; 17(6):2164-2177.